Parallax Volatility Advisers
TMO icon

Parallax Volatility Advisers’s Thermo Fisher Scientific TMO Stock Holding History

Parallax Volatility Advisers’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-400
Closed -$162K – 1818
2025
Q2 		$162K Sell
400
-4,700
-92% -$1.97M ﹤0.01% 1350
2025
Q1 		$2.54M Sell
5,100
-46,700
-90% -$25.3M 0.01% 804
2024
Q4 		$26.9M Buy
51,800
+9,900
+24% +$5.44M 0.05% 289
2024
Q3 		$25.9M Buy
41,900
+40,700
+3,392% +$24.1M 0.05% 271
2024
Q2 		$664K Buy
1,200
+1,100
+1,100% +$630K ﹤0.01% 1375
2024
Q1 		$58.1K Sell
100
-266,700
-100% -$150M ﹤0.01% 1627
2023
Q4 		$142M Buy
266,800
+72,500
+37% +$35.1M 0.29% 58
2023
Q3 		$98.3M Buy
194,300
+57,900
+42% +$30.9M 0.22% 75
2023
Q2 		$71.2M Sell
136,400
-47,100
-26% -$25.4M 0.15% 106
2023
Q1 		$106M Sell
183,500
-416,600
-69% -$235M 0.22% 73
2022
Q4 		$330M Buy
600,100
+192,200
+47% +$102M 0.51% 25
2022
Q3 		$207M Sell
407,900
-73,200
-15% -$41M 0.32% 41
2022
Q2 		$261M Buy
481,100
+404,200
+526% +$222M 0.25% 69
2022
Q1 		$45.4M Sell
76,900
-60,100
-44% -$34.5M 0.02% 293
2021
Q4 		$91.4M Sell
137,000
-58,200
-30% -$36.3M 0.11% 131
2021
Q3 		$112M Buy
195,200
+62,000
+47% +$34M 0.11% 139
2021
Q2 		$67.2M Sell
133,200
-7,400
-5% -$3.49M 0.09% 147
2021
Q1 		$64.2M Buy
140,600
+61,400
+78% +$29.3M 0.14% 118
2020
Q4 		$36.9M Sell
79,200
-108,300
-58% -$50.8M 0.04% 376
2020
Q3 		$82.8M Sell
187,500
-110,800
-37% -$45.8M 0.06% 276
2020
Q2 		$108M Buy
298,300
+201,100
+207% +$67.4M 0.13% 130
2020
Q1 		$27.6M Buy
97,200
+96,800
+24,200% +$30.5M 0.04% 329
2019
Q4 		$130K Sell
400
-11,600
-97% -$3.52M ﹤0.01% 2084
2019
Q3 		$3.5M Buy
12,000
+3,900
+48% +$1.12M ﹤0.01% 937
2019
Q2 		$2.38M Sell
8,100
-41,100
-84% -$11.3M ﹤0.01% 983
2019
Q1 		$13.5M Sell
49,200
-401,100
-89% -$99.8M 0.02% 399
2018
Q4 		$101M Buy
450,300
+334,700
+290% +$78.5M 0.13% 119
2018
Q3 		$28.2M Sell
115,600
-58,600
-34% -$13.5M 0.03% 223
2018
Q2 		$36.1M Buy
174,200
+61,700
+55% +$13.1M 0.05% 163
2018
Q1 		$23.2M Buy
+112,500
New +$23.6M 0.03% 229
2017
Q4 		– Sell
-10,300
Closed -$1.95M – 4917
2017
Q3 		$1.95M Buy
+10,300
New +$1.87M ﹤0.01% 857
2017
Q2 		– Sell
-3,000
Closed -$461K – 3931
2017
Q1 		$461K Buy
+3,000
New +$459K ﹤0.01% 1530
2016
Q4 		– Sell
-58,800
Closed -$9.35M – 4149
2016
Q3 		$9.35M Buy
58,800
+46,800
+390% +$7.21M 0.02% 458
2016
Q2 		$1.77M Sell
12,000
-10,200
-46% -$1.51M ﹤0.01% 975
2016
Q1 		$3.14M Buy
22,200
+4,900
+28% +$657K 0.01% 739
2015
Q4 		$2.45M Buy
17,300
+14,800
+592% +$1.97M 0.01% 943
2015
Q3 		$305K Buy
2,500
+2,400
+2,400% +$313K ﹤0.01% 1684
2015
Q2 		$13K Sell
100
-100
-50% -$13K ﹤0.01% 3086
2015
Q1 		$26K Sell
200
-2,200
-92% -$284K ﹤0.01% 3444
2014
Q4 		$301K Sell
2,400
-10,600
-82% -$1.29M ﹤0.01% 2477
2014
Q3 		$1.58M Buy
13,000
+12,600
+3,150% +$1.53M 0.01% 1222
2014
Q2 		$48K Buy
400
+100
+33% +$11.8K ﹤0.01% 2983
2014
Q1 		$36K Buy
+300
New +$35.7K ﹤0.01% 2500
2013
Q4 		– Sell
-400
Closed -$37K – 3586
2013
Q3 		$37K Buy
+400
New +$36.2K ﹤0.01% 1963

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Parallax Volatility Advisers's TMO Position: Q1 2026 in Review

Parallax Volatility Advisers sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 1,116 shares — an estimated $647K sold.

Parallax Volatility Advisers first reported a position in TMO in Q2 2013 and held it in 28 quarters. The position peaked at $34.9M in Q3 2021. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Parallax Volatility Advisers reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
  • Parallax Volatility Advisers sold 1,116 Thermo Fisher Scientific shares in Q1 2026, an estimated $647K.
  • Parallax Volatility Advisers first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 28 quarters.
  • Parallax Volatility Advisers's Thermo Fisher Scientific position peaked at $34.9M in Q3 2021.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Parallax Volatility Advisers's 13F filing for Q1 2026, filed 15 May 2026.